Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9639 |
High Similarity |
NPD6797 |
Phase 2 |
0.9581 |
High Similarity |
NPD7251 |
Discontinued |
0.9524 |
High Similarity |
NPD7808 |
Phase 3 |
0.9524 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.9461 |
High Similarity |
NPD7472 |
Approved |
0.9401 |
High Similarity |
NPD7054 |
Approved |
0.9231 |
High Similarity |
NPD7074 |
Phase 3 |
0.9226 |
High Similarity |
NPD3818 |
Discontinued |
0.8994 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8994 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8994 |
High Similarity |
NPD6166 |
Phase 2 |
0.8947 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8802 |
High Similarity |
NPD3882 |
Suspended |
0.8795 |
High Similarity |
NPD2801 |
Approved |
0.875 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8631 |
High Similarity |
NPD3817 |
Phase 2 |
0.8623 |
High Similarity |
NPD1934 |
Approved |
0.8462 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.843 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8418 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8412 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8373 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8268 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8256 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8253 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8208 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8176 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8162 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8081 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8059 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8045 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.8045 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8035 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8023 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7988 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7966 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7929 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7901 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7892 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7882 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7877 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7869 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7829 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7791 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7784 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7784 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7772 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7772 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7772 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7772 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7772 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7772 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7772 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7766 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7765 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7765 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7753 |
Intermediate Similarity |
NPD919 |
Approved |
0.7753 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7744 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7738 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7722 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7684 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.768 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7676 |
Intermediate Similarity |
NPD7240 |
Approved |
0.767 |
Intermediate Similarity |
NPD37 |
Approved |
0.7657 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7653 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7653 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7653 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.764 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.764 |
Intermediate Similarity |
NPD4966 |
Approved |
0.764 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7627 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7619 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7614 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7602 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7588 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7572 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.756 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.755 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7525 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7525 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7514 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7513 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7513 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7512 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7512 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7487 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7487 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7475 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7475 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7471 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7446 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7442 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.743 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7425 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7425 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7389 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7382 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7363 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7337 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7326 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7321 |
Intermediate Similarity |
NPD943 |
Approved |
0.7321 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7278 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7278 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7264 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7264 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7259 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7251 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7241 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7235 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7214 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7209 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7202 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7191 |
Intermediate Similarity |
NPD920 |
Approved |
0.7186 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7184 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7176 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7158 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7156 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7126 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.711 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7107 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7107 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7101 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7088 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7079 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7065 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.699 |
Remote Similarity |
NPD7585 |
Approved |
0.6989 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD1243 |
Approved |
0.6984 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.6983 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6979 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6976 |
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.6971 |
Remote Similarity |
NPD2344 |
Approved |
0.6966 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD3748 |
Approved |
0.6954 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6942 |
Remote Similarity |
NPD7583 |
Approved |
0.6923 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6923 |
Remote Similarity |
NPD9494 |
Approved |
0.6923 |
Remote Similarity |
NPD3226 |
Approved |
0.6916 |
Remote Similarity |
NPD7907 |
Approved |
0.6912 |
Remote Similarity |
NPD5006 |
Approved |
0.6912 |
Remote Similarity |
NPD5005 |
Approved |
0.6911 |
Remote Similarity |
NPD2163 |
Approved |
0.6901 |
Remote Similarity |
NPD6798 |
Discontinued |
0.69 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.69 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6895 |
Remote Similarity |
NPD2403 |
Approved |
0.6893 |
Remote Similarity |
NPD6674 |
Discontinued |
0.6879 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6878 |
Remote Similarity |
NPD5711 |
Approved |
0.6878 |
Remote Similarity |
NPD5710 |
Approved |
0.6875 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6867 |
Remote Similarity |
NPD1091 |
Approved |
0.6863 |
Remote Similarity |
NPD2494 |
Approved |
0.6863 |
Remote Similarity |
NPD2493 |
Approved |
0.6837 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6835 |
Remote Similarity |
NPD8059 |
Phase 3 |
0.6835 |
Remote Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.6833 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6828 |
Remote Similarity |
NPD5353 |
Approved |
0.6822 |
Remote Similarity |
NPD4111 |
Phase 1 |
0.6822 |
Remote Similarity |
NPD4665 |
Approved |
0.6821 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6818 |
Remote Similarity |
NPD6099 |
Approved |
0.6818 |
Remote Similarity |
NPD6100 |
Approved |
0.6816 |
Remote Similarity |
NPD2309 |
Approved |
0.6802 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6798 |
Remote Similarity |
NPD4420 |
Approved |
0.6798 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6792 |
Remote Similarity |
NPD7930 |
Approved |
0.6786 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6784 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6784 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.678 |
Remote Similarity |
NPD3450 |
Approved |
0.678 |
Remote Similarity |
NPD2346 |
Discontinued |
0.678 |
Remote Similarity |
NPD3452 |
Approved |
0.6765 |
Remote Similarity |
NPD2798 |
Approved |
0.6763 |
Remote Similarity |
NPD4583 |
Approved |
0.6763 |
Remote Similarity |
NPD4582 |
Approved |
0.6761
|
Remote Similarity |
NPD2799 |
Discontinued |